Health Committee on April 16th, 2007

Evidence of meeting #47 for Health in the 39th Parliament, 1st session. (The original version is on Parliament’s site, as are the minutes.) The winning word was cdr.

A recording is available from Parliament.

common drug reviewcdrpatientsgeneric drugsprocess

On the agenda

Prescription Drugs

Members speaking

Christiane Gagnon
Bonnie Brown
Steven Fletcher
Luc Malo
Penny Priddy
Dave Batters
Colleen Beaumier
James Lunney
Patricia Davidson
Patrick Brown

Before the committee

Russell Williams  President, Canada's Research-Based Pharmaceutical Companies (Rx & D)
Jim Keon  President, Canadian Generic Pharmaceutical Association
Daniel Billen  Vice-President and General Manager, AMGEN Canada Inc.
Peter Brenders  President and Chief Executive Officer, BIOTECanada
Sean Thompson  Director, Corporate Development, YM Biosciences Inc., BIOTECanada
Mark Ferdinand  Vice-President, Policy, Research, Regulatory and Scientific Affairs, Canada's Research-Based Pharmaceutical Companies (Rx & D)

5:25 p.m.

President and Chief Executive Officer, BIOTECanada

Peter Brenders

Not to the CDR, no.

As spoken

5:25 p.m.

Conservative

Dave Batters Conservative Palliser, SK

Okay. Thank you.

That's all I had, Madam Chair.

As spoken

5:25 p.m.

Bloc

The Vice-Chair Bloc Christiane Gagnon

I know that we would like to continue the meeting, but our allotted time is up. I thank all the witnesses who have contributed to this first look at the CDR. Thank you very much. You are bringing new insight to our deliberations.

The meeting is adjourned.

Translated